Dividend-focused investors often weigh a rules-based index approach against an active, high-conviction strategy. SCHD and TBG both target U.S. companies with durable dividends, yet they rest on fundamentally different frameworks. They do not compete directly as clones; instead, they offer alternative paths toward similar goals of income and lower-volatility equity exposure. Comparing their structure, sector positioning, and cost profiles clarifies which vehicle suits different market environments and why relative positioning matters for long-term fund performance. I also checked this using Tickeron’s AI Screener to see how the two line up against broader industry peers.
SCHD is a passively managed ETF that tracks the Dow Jones U.S. Dividend 100 Index, selecting U.S. stocks with a record of consistent dividend payments and fundamental strength based on financial ratios. Launched in 2011, the fund holds approximately 100 large-cap securities and carries a 0.06% expense ratio, among the lowest in the dividend ETF category. Its largest positions include TXN, MRK, CVX, KO, HD, VZ, PG, and AMGN. Sector exposure is led by consumer staples (roughly 20%), healthcare (about 19%), energy (around 17%), and financials (about 9%), with a smaller technology footprint than broad-market funds. The index is reconstituted annually and reviewed quarterly, delivering transparent, systematic turnover with a large-value profile.
TBG is an actively managed ETF launched in November 2023 and sub-advised by The Bahnsen Group. It seeks income and long-term capital appreciation by investing in roughly 35–40 U.S. companies believed to have the potential to grow dividends over time, and it may also hold REITs and MLPs. The fund carries a net expense ratio of approximately 0.59% and manages a comparatively small asset base. Top holdings include BX, MRK, VZ, CVX, PG, JNJ, and PEP. Its sector breakdown is led by healthcare (about 16%), energy (around 15%), consumer staples (near 14%), financials (roughly 13%), and real estate (about 12%), giving it more concentrated, valuation-driven exposure than SCHD and no binding index constraints.
Both funds sit within the large-value, high-dividend segment of U.S. equities, a group that has drawn renewed attention as investors weigh interest-rate expectations, inflation persistence, and earnings breadth beyond mega-cap technology. Defensive sectors such as healthcare, consumer staples, and energy — heavily represented in both portfolios — tend to hold up in late-cycle or slowing-growth environments, while their dividend yields compete with cash and bond income as rate expectations shift. Energy names remain sensitive to commodity prices and geopolitical developments, while healthcare and staples are influenced by regulatory and pricing dynamics. For TBG, real estate and MLP exposure adds sensitivity to borrowing costs and energy infrastructure demand, creating a slightly different risk profile than SCHD's more traditional large-cap dividend mix.
Over recent weeks and months, both funds have traded within the same broad value/dividend rotation, but their relative positioning has diverged in important ways. SCHD's broader, index-driven diversification and near-zero cost have supported steadier, benchmark-consistent behavior, with its technology and industrial weightings providing some cyclical balance. TBG's concentrated, active mandate has produced more idiosyncratic variation tied to its financials, energy, and real estate holdings, and its higher fee drags on net returns. In recent market cycles, low-cost passive dividend strategies have generally compounded more efficiently, while concentrated active funds require sustained manager skill to overcome the cost disadvantage. TBG's shorter history and smaller liquidity also introduce execution and tracking considerations that SCHD largely avoids.
From what I see in my own process, tools like Tickeron’s AI Screener help surface comparable dividend and value opportunities efficiently by applying customizable filters for industry, fundamentals, and technical signals. I find it useful for quickly narrowing the field before diving into detailed holdings and cost analysis, especially when evaluating how one fund stacks up against peers in the same category.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
SCHD saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 16, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In 37 of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 82%.
The 10-day RSI Indicator for SCHD moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 29 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 69%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SCHD as a result. In 50 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.
SCHD moved below its 50-day moving average on November 19, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The 10-day moving average for SCHD crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 84%.
Following a +1.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCHD advanced for three days, in 265 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
SCHD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 285 of 363 cases where SCHD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows